Trial Profile
A Study to Evaluate Pharmacokinetics and Safety of Evogliptin in Subjects With Hepatic Dysfunction and Control Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Dec 2020
Price :
$35
*
At a glance
- Drugs Evogliptin (Primary)
- Indications Liver dysfunction
- Focus Pharmacokinetics
- Sponsors Dong-A ST
- 27 Nov 2020 Results published in the British Journal of Clinical Pharmacology
- 23 Feb 2018 Status changed from recruiting to completed.
- 21 Aug 2017 Planned End Date changed from 1 Dec 2017 to 1 Jan 2018.